Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. (FNCH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fnch · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$160
Consensus
$160
+2047.4% upside
Low
$160
Median: $159.98 · Last Close: $7.45
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FNCH · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-08-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-04-04 | Jefferies | Maintains | Buy→Buy |
| 2021-04-13 | Jefferies | Maintains | Buy→Buy |
| 2021-04-13 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2021-04-13 | B of A Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Finch Therapeutics Group, Inc. (FNCH) stock. Of the recent 7 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover FNCH.
Analyst Recommendation Trends
FNCH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
Revenue Next Year
$0M
↓ 92.3% YoY
EPS This Year
$-65.10
EPS Next Year
$-55.52
↓ 14.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast FNCH EPS of $-65.10 for the current fiscal year, based on estimates from 1 analysts. The FNCH revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FNCH stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FNCH price target is $159.98 (+2047.4% upside), with an analyst consensus of Buy.
Finch Therapeutics Group, Inc. trades on OTC under the ticker FNCH. The FNCH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
FNCH forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month FNCH price target is $159.98, with a high forecast of $159.98 and a low of $159.98. The median price target is shown in the chart above when available. This implies +2047.4% potential upside from the current price of $7.45.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.